THEMIS MEDICARE LTD.
THEMISMED · General/Diversified · NSE
₹92
Current Market Price
Fair Value (DCF)
₹50
Margin of Safety
-46.2%
Updated 15h ago
YieldIQ Score
46/100
Piotroski F-Score
7/9
Economic Moat
Narrow
Confidence
57%
ROE
—
Debt/Equity
0.25
WACC
11.1%
Market Cap
₹849 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
11.2%
Return on capital employed
EV / EBITDA
—
Enterprise multiple
Debt / EBITDA
—
Leverage vs earnings
Interest Coverage
5.7×
EBIT covers interest
Current Ratio
1.95×
Short-term liquidity
Asset Turnover
0.68×
Revenue per ₹ of assets
Revenue CAGR (3Y)
0.7%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹92.22
Bear case
₹28.5
MoS -223.6%
Base case
₹49.66
MoS -85.7%
Bull case
₹64.72
MoS -42.5%
Ratio Trends
THEMISMED · last 8 annual periods
ROE
7.4%
ROCE
12.0%
Operating Margin
—
Debt / Equity
0.21×
PE
1292.8×
EV / EBITDA
120.0×
Historical Financials
THEMISMED · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹231 Cr | ₹395 Cr | ₹80.1 Cr | ₹97.8 Cr | ₹400 Cr | +14.8% |
| EBITDA | — | ₹111 Cr | ₹91.0 Cr | ₹73.3 Cr | ₹58.1 Cr | -15.0% |
| EBIT | ₹44.6 Cr | ₹92.7 Cr | ₹10.6 Cr | ₹7.4 Cr | — | -36.3% |
| PAT | ₹35.7 Cr | ₹72.9 Cr | ₹8.4 Cr | ₹3.1 Cr | ₹29.8 Cr | -4.4% |
| EPS (diluted) | ₹38.84 | ₹79.07 | ₹9.12 | ₹0.34 | — | -69.4% |
| CFO | ₹57.0 Cr | ₹34.4 Cr | ₹16.1 Cr | ₹22.0 Cr | ₹34.7 Cr | -11.7% |
| CapEx | — | — | — | — | ₹-15.4 Cr | — |
| FCF | — | — | — | — | ₹19.3 Cr | +0.0% |
| Total Assets | — | ₹428 Cr | ₹514 Cr | ₹490 Cr | ₹588 Cr | +8.3% |
| Total Debt | — | — | ₹63.5 Cr | ₹69.0 Cr | ₹83.0 Cr | +6.9% |
| Shareholders' Equity | — | — | ₹339 Cr | ₹301 Cr | ₹403 Cr | +4.4% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
THEMISMED vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| ANUHPHR ANUHPHR | — | — | Pending | 14.5% | — |
| SIGACHI SIGACHI | — | — | Pending | 11.3% | — |
| WANBURY WANBURY | — | — | Pending | 51.5% | — |
| AHCL AHCL | — | — | Pending | 25.5% | — |
| AMANTA AMANTA | — | — | Pending | 10.9% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for THEMISMED in the last 10 years.
AI Analysis Summary
Model-generated description of metrics. Not investment advice. THEMIS MEDICARE LTD. (THEMISMED.NS) trades at 92.22 vs a model fair value of 49.66, a gap of -46.2%. Piotroski F-score: 7/9. Moat label: ...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of THEMISMED →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for THEMISMED →
Compare
Head-to-head with peers
Compare THEMISMED side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse THEMISMEDNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.